Company News

AARDEX Group and BIOCORP Recruited by Trials@Home – Decentralized Trial Centre of Excellence

Combining BIOCORP’s pen injector add-on with AARDEX® Group’s Software to improve adherence to medication in a Hybrid Phase IV Diabetes Study. Liege, Belgium – July 19, 2022: Following the launch of their global collaboration to support medication adherence in different fields last … Read More

Patient Adherence Behaviors

Why Patient Adherence Behaviours Should Be Common Knowledge in Clinical Trials

Realizing the potential of the revolution in cancer treatment depends on ensuring researchers, regulators, and clinicians have access to all the information they need to develop, approve, and prescribe new drugs – including patient adherence data. Nothing stops a drug … Read More

Smart Caps Improve Patient Adherence

Smart Caps Improve Medication Adherence in Clinical Trials – It’s a Fact!

Poor medication adherence is a problem that has gone “unsolved” for decades. But combining smart caps with individualized feedback can drive the adherence that proves the investigational product efficacy and underwrites approvals. In this case study, we set out the … Read More

Measure Medication Adherence

High Fidelity Measurement of Patients’ Medication Adherence: A Missing Link in Precision Medicine

The emergence of pharmacogenomics is an important milestone in the precision medicine journey – but the importance of measuring medicine adherence, an essential component in the complex pharmacokinetics/ pharmacodynamics equation, can often be overlooked. In this article, Bernard Vrijens, CEO … Read More

May 2022 News

Clincal Trials and Tribulations Newsletter – May 2022 Edition

Welcome to the May edition of AARDEX Group’s Clinical Trials and Tribulations Newsletter – an aggregated collective of all of the industry’s hottest news and views!  Breaking News New Pivotal Data Demonstrates the Clinical Benefit of Roche’s glofitamab, a Potential … Read More

Poor Patient Adherence

In a world of outcome-based pricing, can you afford to neglect patient adherence? 

The emergence of outcome-based contracts in clinical research has placed an additional consideration on the already thorny issue of adherence. When drug companies are paid according to the real-world effectiveness of their products, ensuring people take the medications as prescribed … Read More

Adherence to Medication

Adherence to Medication: The Missing Piece in the Pharmacogenomics Puzzle

If enacted, the US’ Right Drug Dose Now Act will place pharmacogenomics on the main stage of drug development and move us further into the personalized medicine era. By supporting the use of pharmacogenetic testing to prevent adverse events (AEs) … Read More

smart pill bottles

Harnessing Smart Pill Bottles to Improve Patient Adherence in Clinical Research

“Nothing stops a drug from working like not taking it, making patient adherence one of the most important factors to consider when designing a clinical trial.”  – Bernard Vrijens, Scientific Lead, AARDEX® Group Poor patient adherence is a problem that has … Read More

The Role of Medication Adherence Tools

The Heart of the Matter: The Role of Medication Adherence Tools in Tackling the CVD Epidemic

Despite huge strides in how cardiovascular diseases (CVD) are treated in recent years, the conditions remain among the leading causes of morbidity and mortality worldwide. At least part of the problem is that even the most effective drugs will not … Read More

Smart Pills

AARDEX® Group adds etectRx’s Smart Pills to their MEMS® Adherence Hardware ecosystem 

The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor smart pill. Liege, Belgium (APRIL 28, 2022) – Belgium-based AARDEX Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic … Read More